Marek Wardęcki
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Hematology top 10%
- Blood groups and transfusion
- Platelet Disorders and Treatments
Papers in
- Hematology 14
- Blood groups and transfusion 14
- Platelet Disorders and Treatments 6
-
- Diabetes Management and Research 10
- Diabetes Treatment and Management 4
- Co-authors
- Richard M. Bergenstal (7 shared papers)Matthew C. Riddle (6 shared papers)Monika Ziemen (6 shared papers)Isabel Muehlen-Bartmer (6 shared papers)Hannele Yki‐Järvinen (3 shared papers)Emmanuelle Boëlle (1 shared paper)Geremia B. Bolli (5 shared papers)Hannele Yki-Järvinen (2 shared papers)
- Journals
- Blood (4 papers)Diabetes Technology & Therapeutics (3 papers)Diabetes Care (3 papers)American Journal of Hematology (3 papers)EClinicalMedicine (2 papers)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Marek Wardęcki
25 papers receiving 740 citations
Peers
Comparison fields: 5 of 37
- Endocrinology, Diabetes and Metabolism 494
- Hematology 139
- Surgery 129
- Genetics 76
- Physiology 63
Countries citing papers authored by Marek Wardęcki
This map shows the geographic impact of Marek Wardęcki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Wardęcki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Wardęcki more than expected).
Fields of papers citing papers by Marek Wardęcki
This network shows the impact of papers produced by Marek Wardęcki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Wardęcki. The network helps show where Marek Wardęcki may publish in the future.
Co-authors
The 25 scholars most cited alongside Marek Wardęcki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 227 | |
| 2 | 2016 | 111 | |
| 3 | 2015 | 105 | |
| 4 | 2022 | 84 | |
| 5 | 2017 | 43 | |
| 6 | 2016 | 37 | |
| 7 | 2023 | 20 | |
| 8 | 2019 | 20 | |
| 9 | 2020 | 18 | |
| 10 | 2023 | 16 | |
| 11 | 2022 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2014 | 9 | |
| 15 | 2023 | 9 | |
| 16 | 2020 | 7 | |
| 17 | 2024 | 7 | |
| 18 | 2014 | 5 | |
| 19 | New insulin glargine 300 U/ml: efficacy and safety of flexible vs fixed dosing intervals in people with type 2 diabetes mellitus | 2014 | 5 |
| 20 | 2022 | 4 |
About Marek Wardęcki
Marek Wardęcki is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism, Genetics, Physiology and Immunology, having authored 25 papers that have together received 765 indexed citations. Recurring topics across this work include Blood groups and transfusion (14 papers), Diabetes Management and Research (10 papers), Erythrocyte Function and Pathophysiology (7 papers), Platelet Disorders and Treatments (6 papers), Diabetes Treatment and Management (4 papers), Pancreatic function and diabetes (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (494 citations), Hematology (139 citations), Surgery (129 citations), Genetics (76 citations) and Physiology (63 citations). Marek Wardęcki has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Richard M. Bergenstal, Matthew C. Riddle, Monika Ziemen, Isabel Muehlen-Bartmer, Hannele Yki‐Järvinen, Emmanuelle Boëlle, Geremia B. Bolli, Hannele Yki-Järvinen, Philip Home and Ronnie Aronson. Their work appears in journals such as Blood, Diabetes Technology & Therapeutics, Diabetes Care, American Journal of Hematology and EClinicalMedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.